Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Biologic therapies in inflammatory bowel disease.

Cohen LB, Nanau RM, Delzor F, Neuman MG.

Transl Res. 2014 Jun;163(6):533-56. doi: 10.1016/j.trsl.2014.01.002. Epub 2014 Jan 7. Review.

PMID:
24467968
[PubMed - indexed for MEDLINE]
2.

Biologic therapy for inflammatory bowel disease.

Ardizzone S, Bianchi Porro G.

Drugs. 2005;65(16):2253-86. Review.

PMID:
16266194
[PubMed - indexed for MEDLINE]
3.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
[PubMed - indexed for MEDLINE]
4.

Role of the tumor necrosis factor antagonists in the treatment of inflammatory bowel disease: an update.

Leso V, Leggio L, Armuzzi A, Gasbarrini G, Gasbarrini A, Addolorato G.

Eur J Gastroenterol Hepatol. 2010 Jul;22(7):779-86. doi: 10.1097/MEG.0b013e328331b654. Review.

PMID:
19786877
[PubMed - indexed for MEDLINE]
5.

New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis?

Danese S, Angelucci E.

Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S217-27. doi: 10.1016/S0399-8320(09)73157-4. Review.

PMID:
20117345
[PubMed - indexed for MEDLINE]
Free Article
6.

Anti-TNF-alpha treatment strategies: results and clinical perspectives.

D'Haens G.

Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S209-16. doi: 10.1016/S0399-8320(09)73156-2.

PMID:
20117344
[PubMed - indexed for MEDLINE]
Free Article
7.

Mechanisms and efficacy of immunobiologic therapies for inflammatory bowel diseases.

Ghosh N, Chaki R, Mandal V, Lin GD, Mandal SC.

Int Rev Immunol. 2010;29(1):4-37. doi: 10.3109/08830180903437212. Review.

PMID:
20100080
[PubMed - indexed for MEDLINE]
8.

Novel targets for inflammatory bowel disease therapeutics.

Löwenberg M, D'Haens G.

Curr Gastroenterol Rep. 2013 Feb;15(2):311. doi: 10.1007/s11894-012-0311-3. Review.

PMID:
23314806
[PubMed - indexed for MEDLINE]
9.

[Biologic therapies in chronic inflammatory bowel diseases].

Reenaers C, Louis E, Belaiche J.

Rev Med Liege. 2009 May-Jun;64(5-6):301-4. French.

PMID:
19642463
[PubMed - indexed for MEDLINE]
10.
11.

Positioning biologic therapy for Crohn's disease and ulcerative colitis.

Velayos FS, Sandborn WJ.

Curr Gastroenterol Rep. 2007 Dec;9(6):521-7. Review.

PMID:
18377806
[PubMed - indexed for MEDLINE]
12.

Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.

Lee TW, Fedorak RN.

Gastroenterol Clin North Am. 2010 Sep;39(3):543-57. doi: 10.1016/j.gtc.2010.08.018. Review.

PMID:
20951917
[PubMed - indexed for MEDLINE]
13.

Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease.

Chang JT, Lichtenstein GR.

Nat Clin Pract Gastroenterol Hepatol. 2006 Apr;3(4):220-8. Review.

PMID:
16582964
[PubMed - indexed for MEDLINE]
14.

Recent developments in the treatment of inflammatory bowel disease.

Rietdijk ST, D'Haens GR.

J Dig Dis. 2013 Jun;14(6):282-7. doi: 10.1111/1751-2980.12048. Review.

PMID:
23419117
[PubMed - indexed for MEDLINE]
15.

Novel biologics in inflammatory bowel disease.

Papachristou GI, Plevy S.

Gastroenterol Clin North Am. 2004 Jun;33(2):251-69, ix. Review.

PMID:
15177537
[PubMed - indexed for MEDLINE]
16.

Management of inflammatory bowel disease: past, present and future.

Keyashian K, Annunziata ML, Sakuraba A, Hanauer S.

Expert Rev Clin Immunol. 2012 May;8(4):303-5. doi: 10.1586/eci.12.13. Review. No abstract available.

PMID:
22607175
[PubMed - indexed for MEDLINE]
17.

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.

Behm BW, Bickston SJ.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006893. doi: 10.1002/14651858.CD006893. Review.

PMID:
18254120
[PubMed - indexed for MEDLINE]
18.

Certolizumab pegol for the management of Crohn's disease in adults.

Rivkin A.

Clin Ther. 2009 Jun;31(6):1158-76. doi: 10.1016/j.clinthera.2009.06.015. Review.

PMID:
19695385
[PubMed - indexed for MEDLINE]
19.

Current directions of biologic therapies in inflammatory bowel disease.

Reenaers C, Louis E, Belaiche J.

Therap Adv Gastroenterol. 2010 Mar;3(2):99-106. doi: 10.1177/1756283X09356872.

PMID:
21180594
[PubMed]
Free PMC Article
20.

[TNF-alpha blocking therapy in chronic inflammatory bowel disease].

Molnár T.

Orv Hetil. 2009 Sep 20;150(38):1773-9. doi: 10.1556/OH.2009.28689. Review. Hungarian.

PMID:
19740722
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk